MaaT Pharma Shares Jump 3.2% After a 68% Surge Over Three Months
MaaT Pharma's stock increases by 3.2% this Thursday morning to 7.10 euros, after closing at 6.88 euros the previous day. This rebound occurs in a context of strong appreciation over three months, with the Lyon-based biotech showing a performance of nearly 68% during this period. However, the stock has declined by 4% over the past seven days.
Current Performance and Long-term Trends
MaaT Pharma, a specialist in microbiota-based therapies, sees its price set at 7.10 euros this morning of March 5. Today's increase partially offsets the decline observed over the past week, with a decrease of 4.05% over seven days. In the longer term, the trajectory remains significantly bullish: the stock has gained nearly 68% in three months and shows an annual performance of 17.94%. The current price is well above its 50-day moving average (6.20 euros) and even more so above its 200-day moving average (5.00 euros), indicating a strong upward trend over several months. Nonetheless, the Relative Strength Index (RSI) stands at 44, a neutral level that signals neither overbuying nor overselling, consistent with a short-term consolidation phase.
Technical Analysis
Technically, MaaT Pharma's stock fluctuates within a relatively narrow corridor. The identified resistance is at 7.78 euros, a level that almost exactly coincides with the upper Bollinger band at 7.79 euros. Crossing this level would signal a continuation of the bullish trend, while the major support is positioned at 5.10 euros, well below the current prices. The negative beta of the stock, at -0.44, indicates a low correlation with benchmark indices, a common characteristic of biotechnological companies whose evolution depends more on clinical advancements than on the macroeconomic context. The monthly volatility, measured at 13.22%, remains moderate for a company of this size in the sector. The stock thus moves in the lower part of its Bollinger bands (lower bound at 6.80 euros), suggesting that it was recently approaching a compression zone before the rebound observed this morning.
